节点文献

肝门部胆管癌外科治疗预后影响因素分析

Influencing factors of prognosis in patients with hilar cholangiocarcinoma after surgical treatment

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 刘连杰王石王烯冬武志雄

【Author】 Liu Lianjie;Wang Shi;Wang Xidong;Department of Hepatobiliary,Pancreatic and Splenic Surgery,Provincial People’s Hospital;

【机构】 内蒙古自治区人民医院肝胆胰脾外科

【摘要】 目的探讨影响外科治疗肝门部胆管癌(HCCA)患者预后的因素。方法 2010年1月~2014年1月收治的HCCA患者120例,行手术切除者67例【其中行根治性切除30例,姑息性切除(R1,R2)37例】和行胆管引流术53例(内引流术30例,外引流术23例)。结果 120例HCCA患者术后1 a、2 a、3 a生存率分别为67.5%(81/120)、45.8%(55/120)、25.0%(30/120),其中根治性切除患者1 a、2 a、3 a生存率分别为93.33%、73.33%、60.00%,生存时间为(30.26±5.26)m,显著高于姑息性切除患者的(67.57%、48.65%、32.43%)和(22.14±4.78)m或胆管引流术患者【(52.83%、28.30%、0.0%)和(15.21±3.74)m,P<0.05】,姑息性切除患者上述指标又显著高于胆管引流术患者(P<0.05);COX多因素分析显示,手术方式、切缘情况、细胞分化程度、TNM分期、淋巴结转移和门静脉侵犯均为影响HCCA患者外科治疗后生存的独立危险因素(P<0.05)。结论影响HCCA患者治疗后预后的因素较多,应针对性地做出评估,给予合理的治疗,以使患者最大获益。

【Abstract】 Objective To investigate the influencing factors of prognosis in patients with hilar cholangiocarcinoma(HCCA) after surgical treatment. Methods 120 patients with HCCA were recruited in our hospital between January 2010 and January 2014,and 67 patients received surgical resection,including 30 with radical resection and 37 with R1 or R2 palliative resection,and 53 received bile duct drainage. Results The 1-year,2-year and 3-year survival rates in the 120 patients with HCCA were 67.5%(81/120),45.8%(55/120) and25%(30/120),respectively,after treatment,and the 1-year,2-year and 3-year survival rates in patients undergoing radical resection were 93.33%,73.33%,60.00%,and the survival time was(30.26±5.26) months,much higher than67.57%,48.65%,32.43% or longer than(22.14±4.78) m in patients with palliative resection or 52.83%,28.30%,0.0% and(15.21±3.74) m in patients with bile duct drainage(P<0.05);Cox multivariate analysis showed that the surgical method [Exp(β)=5.214],resection margin [Exp(β)=2.703],differentiation degree [Exp(β)=4.781],TNM stage [Exp(β)=6.987],lymph node metastasis [Exp(β)=2.751] and portal vein invasion [Exp(β)=3.254] were the independent risk factors for the prognosis of patients with HCCA after treatment(P <0.05). Conclusion Precise surgery should be given in patients with HCCA with detailed analysis of influencing factors of prognosis, which might be evaluated before any approaches is taken.

【关键词】 肝门部胆管癌外科手术预后
【Key words】 Hilar cholangiocarcinomaSurgeryPrognosis
【基金】 内蒙古自治区科学技术厅科研项目(编号:201602097)
  • 【文献出处】 实用肝脏病杂志 ,Journal of Practical Hepatology , 编辑部邮箱 ,2018年04期
  • 【分类号】R735.8
  • 【被引频次】5
  • 【下载频次】110
节点文献中: 

本文链接的文献网络图示:

本文的引文网络